Skip to main content

Advertisement

Log in

Central leptin versus ghrelin: effects on bone marrow adiposity and gene expression

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

This study compared the central effects of ghrelin and leptin on body and bone marrow adiposity and gene expression in adipose tissue and bone marrow. Male Sprague–Dawley rats were injected intracerebroventricular (ICV) twice daily with control, 66 ng ghrelin (G66), 330 ng ghrelin (G330), or 5 μg leptin (L5) for 5 days. Food intake (FI) and body weight (BW) were measured daily. Gene expression in adipose tissue and bone marrow was assessed using RT–PCR. Leptin reduced FI (P < 0.05) and BW (P < 0.05), whereas ghrelin increased BW (P < 0.05) without affecting FI. Leptin decreased fat pad weights, whereas ghrelin (G330) increased fat pad weights (P < 0.05). In epididymal adipose tissue, leptin increased expression of lipolysis marker ADRB2 and thermogenesis marker MFN2 and decreased expression of adipogenic markers, FASN, SLC2A4, and SCD1, whereas ghrelin increased expression of FASN and SCD1. Leptin decreased bone marrow adipocyte size and number; however, ghrelin had no effect on these parameters. In whole bone marrow, leptin decreased expression of FASN and SCD1 and increased expression of DLK1, whereas ghrelin (G330) decreased expression of COL1A1. Thus, leptin induces similar changes in bone marrow and adipose tissue gene expression, reflecting the decreased adiposity in both compartments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ADRB2:

Adrenergic, beta-2 receptor

ALPL:

Alkaline phosphatase

ANXA5:

Annexin A5

BBC3:

Bcl-2 binding component 3

BGLAP:

Bone gamma-carboxy glutamate (gla) protein

BGN:

Biglycan

BMP2:

Bone morphogenetic protein 2

CASP2:

Caspase 2

CD36:

CD36 molecule (thrombospondin receptor)

CEBPA:

CCAAT/enhancer binding protein (C/EBP), alpha

COLIA1:

collagen type I alpha 1

CTSK:

Cathepsin K

DLK1:

Delta-like 1 homolog

EGF:

Epidermal growth factor

FABP4:

Fatty acid binding protein 4

FASN:

Fatty acid synthase

FGF14:

Fibroblast growth factor 14

FN1:

Fibronectin 1

GAPDH:

Glyceraldehyde-3-phosphate

GATA-3:

GATA binding protein 3

GPD1:

Glycerol-3-phosphate dehydrogenase 1

LEP:

Leptin

LEPR:

Leptin receptor

LIPE:

Lipase, hormone-sensitive

LPL:

Lipoprotein lipase

SMAD1:

SMAD family member 1

MFN 2:

Mitofusin 2

MMP11:

Matrix metallopeptidase 11

PPARα:

Peroxisome-proliferator-activated receptor alpha

PPARγ:

Peroxisome-proliferator-activated receptor gamma

RTN:

RTN hypothetical protein

SCD1:

Stearoyl-CoA desaturase 1

SERPINH1:

Serine (or cysteine) peptidase inhibitor, clade H member 1

SLC2A4:

Solute carrier family 2 (facilitated glucose transporter), member 4

SPARC:

Secreted protein, acidic cysteine-rich (osteonectin)

SRA1:

Steroid receptor RNA activator 1

TNF:

Tumor necrosis factor

UCP1:

Uncoupling protein 1

UCP3:

Uncoupling protein 2

UCP3:

Uncoupling protein 3

VEGF:

Vascular endothelial growth factor precursor

EP:

Epididymal fat pad

RP:

Retroperitoneal fat pad

ING:

Inguinal fat pad

GC:

Gastrocnemius muscle

References

  1. Y.-H. Choi, C.L. Li, D. Hartzell, D.E. Little, M.A. Della-Fera, C.A. Baile, ICV leptin effects on spontaneous physical activity and feeding behavior in rats. Behav. Brain Res. 188, 100–108 (2008)

    Article  CAS  PubMed  Google Scholar 

  2. M.A. Della-Fera, H. Qian, C.A. Baile, Adipocyte apoptosis in the regulation of body fat mass by leptin. Diabetes Obes. Metab. 3, 299–310 (2001)

    Article  CAS  PubMed  Google Scholar 

  3. G. Fruhbeck, M. Aguado, J. Gomez-Ambrosi, J.A. Martinez, Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem. Biophys. Res. Commun. 250, 99–102 (1998)

    Article  CAS  PubMed  Google Scholar 

  4. P. Ducy, M. Amling, S. Takeda, M. Priemel, A.F. Schilling, F.T. Beil, J. Shen, C. Vinson, J.M. Rueger, G. Karsenty, Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197–207 (2000)

    Article  CAS  PubMed  Google Scholar 

  5. F. Elefteriou, S. Takeda, K. Ebihara, J. Magre, N. Patano, C.A. Kim, Y. Ogawa, X. Liu, S.M. Ware, W.J. Craigen, J.J. Robert, C. Vinson, K. Nakao, J. Capeau, G. Karsenty, Serum leptin level is a regulator of bone mass. Proc. Natl Acad. Sci. USA 101, 3258–3263 (2004)

    Article  CAS  PubMed  Google Scholar 

  6. T. Thomas, The complex effects of leptin on bone metabolism through multiple pathways. Curr. Opin. Pharmacol. 4, 295–300 (2004)

    Article  CAS  PubMed  Google Scholar 

  7. M.W. Hamrick, S.L. Ferrari, Leptin and the sympathetic connection of fat to bone. Osteoporos. Int. 19, 905–912 (2008)

    Article  CAS  PubMed  Google Scholar 

  8. W.R. Holloway, F.M. Collier, C.J. Aitken, D.E. Myers, J.M. Hodge, M. Malakellis, T.J. Gough, G.R. Collier, G.C. Nicholson, Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17, 200–209 (2002)

    Article  CAS  PubMed  Google Scholar 

  9. J.O. Gordeladze, C.A. Drevon, U. Syversen, J.E. Reseland, Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J. Cell. Biochem. 85, 825–836 (2002)

    Article  CAS  PubMed  Google Scholar 

  10. T. Thomas, F. Gori, S. Khosla, M.D. Jensen, B. Burguera, B.L. Riggs, Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630–1638 (1999)

    Article  CAS  PubMed  Google Scholar 

  11. M.W. Hamrick, M.A. Della-Fera, Y.H. Choi, D. Hartzell, C. Pennington, C.A. Baile, Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow. Cell Tissue Res. 327, 133–141 (2007)

    Article  CAS  PubMed  Google Scholar 

  12. M.W. Hamrick, M.A. Della-Fera, Y.H. Choi, C. Pennington, D. Hartzell, C.A. Baile, Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J. Bone Miner. Res. 20, 994–1001 (2005)

    Article  CAS  PubMed  Google Scholar 

  13. M. Tschop, D.L. Smiley, M.L. Heiman, Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000)

    Article  CAS  PubMed  Google Scholar 

  14. C. Theander-Carrillo, P. Wiedmer, P. Cettour-Rose, R. Nogueiras, D. Perez-Tilve, P. Pfluger, T.R. Castaneda, P. Muzzin, A. Schurmann, I. Szanto, M.H. Tschop, F. Rohner-Jeanrenaud, Ghrelin action in the brain controls adipocyte metabolism. J. Clin. Invest. 116, 1983–1993 (2006)

    Article  CAS  PubMed  Google Scholar 

  15. N. Fukushima, R. Hanada, H. Teranishi, Y. Fukue, T. Tachibana, H. Ishikawa, S. Takeda, Y. Takeuchi, S. Fukumoto, K. Kangawa, K. Nagata, M. Kojima, Ghrelin directly regulates bone formation. J. Bone Miner. Res. 20, 790–798 (2005)

    Article  CAS  PubMed  Google Scholar 

  16. K. Matsumura, T. Tsuchihashi, K. Fujii, I. Abe, M. Iida, Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 40, 694–699 (2002)

    Article  CAS  PubMed  Google Scholar 

  17. N. Gallardo, E. Bonzon-Kulichenko, T. Fernandez-Agullo, E. Molto, S. Gomez-Alonso, P. Blanco, J.M. Carrascosa, M. Ros, A. Andres, Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 148, 5604–5610 (2007)

    Article  CAS  PubMed  Google Scholar 

  18. W. Zhang, M.A. Della-Fera, D.L. Hartzell, D. Hausman, C.A. Baile, Adipose tissue gene expression profiles in ob/ob mice treated with leptin. Life Sci. 83, 35–42 (2008)

    Article  CAS  PubMed  Google Scholar 

  19. A.M. Wren, C.J. Small, C.R. Abbott, W.S. Dhillo, L.J. Seal, M.A. Cohen, R.L. Batterham, S. Taheri, S.A. Stanley, M.A. Ghatei, S.R. Bloom, Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547 (2001)

    Article  CAS  PubMed  Google Scholar 

  20. R. Nogueiras, M.H. Tschop, J.M. Zigman, Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann. N. Y. Acad. Sci. 1126, 14–19 (2008)

    Article  CAS  PubMed  Google Scholar 

  21. M. Yukawa, D.S. Weigle, C.D. Davis, B.T. Marck, T. Wolden-Hanson, Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1453–R1460 (2008)

    CAS  PubMed  Google Scholar 

  22. S. Strassburg, S.D. Anker, T.R. Castaneda, L. Burget, D. Perez-Tilve, P.T. Pfluger, R. Nogueiras, H. Halem, J.Z. Dong, M.D. Culler, R. Datta, M.H. Tschop, Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. 295, E78–E84 (2008)

    Article  CAS  PubMed  Google Scholar 

  23. V. Cirmanova, M. Bayer, L. Starka, K. Zajickova, The effect of leptin on bone: an evolving concept of action. Physiol. Res. 57(Suppl 1), S143–S151 (2008)

    CAS  PubMed  Google Scholar 

  24. C. Garces, M.J. Ruiz-Hidalgo, E. Bonvini, J. Goldstein, J. Laborda, Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation 64, 103–114 (1999)

    CAS  PubMed  Google Scholar 

  25. B.M. Abdallah, P. Boissy, Q. Tan, J. Dahlgaard, G.A. Traustadottir, K. Kupisiewicz, J. Laborda, J.M. Delaisse, M. Kassem, dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J. Biol. Chem. 282, 7339–7351 (2007)

    Article  CAS  PubMed  Google Scholar 

  26. Y.H. Choi, C. Li, K. Page, A. Westby, M.A. Della-Fera, J. Lin, D.L. Hartzell, C.A. Baile, Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis. Physiol. Behav. 79, 795–801 (2003)

    Article  CAS  PubMed  Google Scholar 

  27. M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, K. Takaya, T. Hayashi, G. Inoue, K. Hosoda, M. Kojima, K. Kangawa, K. Nakao, Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227–232 (2001)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported in part by Georgia Research Alliance Eminent Scholar endowment held by CAB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clifton A. Baile.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ambati, S., Li, Q., Rayalam, S. et al. Central leptin versus ghrelin: effects on bone marrow adiposity and gene expression. Endocr 37, 115–123 (2010). https://doi.org/10.1007/s12020-009-9274-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-009-9274-z

Keywords

Navigation